These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35102367)

  • 1. Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study.
    Lindgren M; Nielsen SJ; Björklund E; Pivodic A; Perrotta S; Hansson EC; Jeppsson A; Martinsson A
    Eur Heart J Cardiovasc Pharmacother; 2022 Aug; 8(5):529-536. PubMed ID: 35102367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
    Zhang H; Yuan X; Zhang H; Chen S; Zhao Y; Hua K; Rao C; Wang W; Sun H; Hu S; Zheng Z
    Circulation; 2015 Jun; 131(25):2194-201. PubMed ID: 25908770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study.
    Wen XS; Luo R; Liu J; Duan Q; Qin S; Xiao J; Zhang DY
    BMC Cardiovasc Disord; 2022 Apr; 22(1):193. PubMed ID: 35473676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease.
    Tsujimoto T; Sugiyama T; Kajio H
    Diabetes Obes Metab; 2017 Jun; 19(6):800-808. PubMed ID: 28094466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
    Holzmann MJ; Sartipy U
    Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Björklund E; Nielsen SJ; Hansson EC; Karlsson M; Wallinder A; Martinsson A; Tygesen H; Romlin BS; Malm CJ; Pivodic A; Jeppsson A
    Eur Heart J; 2020 May; 41(17):1653-1661. PubMed ID: 31638654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Outcomes of Multiple Arterial Coronary Artery Bypass Grafting: A Population-Based Study of Patients in British Columbia, Canada.
    Pu A; Ding L; Shin J; Price J; Skarsgard P; Wong DR; Bozinovski J; Fradet G; Abel JG
    JAMA Cardiol; 2017 Nov; 2(11):1187-1196. PubMed ID: 29049458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction.
    Desta L; Khedri M; Jernberg T; Andell P; Mohammad MA; Hofman-Bang C; Erlinge D; Spaak J; Persson H
    ESC Heart Fail; 2021 Feb; 8(1):344-355. PubMed ID: 33259148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term and long-term outcomes of revascularization interventions for patients with severely reduced left ventricular ejection fraction: a meta-analysis.
    Pei J; Wang X; Xing Z; Zheng K; Hu X
    ESC Heart Fail; 2021 Feb; 8(1):634-643. PubMed ID: 33274612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of preoperative beta-blocker use for isolated coronary artery bypass grafting: A systematic review and meta-analysis.
    Wang L; Wang H; Hou X
    J Thorac Cardiovasc Surg; 2018 Feb; 155(2):620-629.e1. PubMed ID: 28918203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for secondary prevention and major adverse events after coronary artery bypass grafting.
    Pan E; Nielsen SJ; Mennander A; Björklund E; Martinsson A; Lindgren M; Hansson EC; Pivodic A; Jeppsson A
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1875-1886.e4. PubMed ID: 34893327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
    Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
    Trials; 2020 May; 21(1):415. PubMed ID: 32446298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of coronary artery bypass grafting in patients with heart failure with a midrange ejection fraction.
    Deo SV; Sundaram V; Sahadevan J; Selvaganesan P; Mohan SM; Rubelowsky J; Josephson R; Elgudin Y; Kilic A; Cmolik B
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):149-158.e4. PubMed ID: 33618872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and prognosis of patients with left ventricular thrombus in East China.
    Li C; Lau W; Qian N; Song L; Jin C; Zhou D; Yu Y; Pan X; Zhou Q
    Front Cardiovasc Med; 2022; 9():944687. PubMed ID: 36158827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-Blockers and Cardiovascular Outcomes in Acute Heart Failure with a History of Coronary Artery Disease and an Ejection Fraction ≥ 40.
    Abi Khalil C; Sulaiman K; Asaad N; AlHabib KF; Alsheikh-Ali A; Jameesh M; Al-Jarallah M; Bulbanat B; AlMahmeed W; Ridha M; Bazargani N; Amin H; Al-Motarreb A; AlFaleh H; Panduranga P; Mahfoud Z; Al Suwaidi J
    Curr Vasc Pharmacol; 2020; 18(6):644-651. PubMed ID: 31889498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
    Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.